India Thyroid Function Test Market Worth US$ 58.9 Million With a CAGR of 3.7% By 2027 | Merck (Sigma-Aldrich Co. LLC.), Abbott Laboratories, Beckman Coulter Diagnostics, Siemens Healthcare

Thyroid is the main gland that produces hormones, T4 and T3. Its mechanism controls the normal levels of these hormones in blood. It is like a central heating thermostat. Once you have set the desired temperature, the furnace or boiler will activate. In the same way, the thyroid acts in a similar manner. Once the level of a thyroid hormone increases or decreases, the body responds by regulating its levels. To monitor your thyroid’s health, you should have your doctor examine it frequently.

Thyroid disorders may affect you at any age. While the most common causes are overproduction of T4 and T3, you can also suffer from an underactive thyroid. In such cases, your pituitary gland, which is located in the center of your skull, can secrete TSH, which controls the activity of the thyroid. Thyroid hormone levels are controlled by the pituitary gland. Despite its importance in your body, you shouldn’t take thyroid medication without consulting a doctor.

India thyroid function test market is estimated to account for US$ 44.5 Mn in terms of value in 2018 and is expected to reach US$ 58.9 Mn by the end of 2027.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/3521

India Thyroid Function Test Market: Drivers  

Investment in R&D is expected to propel growth of India thyroid function test market over the forecast period. For instance, in January 2020, Merck started a non-profit center R&D learning in genome-editing and single-molecule biomolecule biomarker detection technologies from Merck team, in Chandigarh, India.

Moreover, R&D in thyroid dysfunction is also expected to propel growth of India thyroid function test market over the forecast period. For instance, in November 2019, a Catholic University of Korea study found out that shorter and longer sleep durations can be linked to higher risk of subclinical thyroid dysfunction compared to an ideal sleep pattern.

Key Takeaways

TSH held dominant position in India thyroid function test market in 2018, accounting for 61.1% share in terms of value, followed by T4.

Hospitals segment in India thyroid function test market was valued at US$ 24.0 in 2018 and is expected to reach US$ 33.2 Mn by 2027 at a CAGR of 3.7% during the forecast period.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/3521

Market Trends

High prevalence of hyperthyroidism is expected to contribute to growth of India thyroid function test market. For instance, prevalence of hypothyroidism in India is reported to be around 10.9%, According to Indian Journal of Endocrinology and Metabolism, 2017.

High prevalence of hypothyroidism in patients with type 2 diabetes and hypertension is also expected contribute to growth of the market. For instance, the prevalence of hypothyroidism in patients with type 2 diabetes mellitus, hypertension, and type 2 diabetes mellitus + hypertension was 24.8%, 33.5%, and 28.9%, respectively, according to a cross-sectional observational study published in in March 2019.

India Thyroid Function Test Market: Restraints

Low awareness about thyroid diseases and use of fraudulent or bogus reagents in tests is expected to hinder growth of India thyroid function test market.

India Thyroid Function Test Market: Competitive Landscape

Major players operating in India thyroid function test market include, Abbott Laboratories, bioMérieux, Beckman Coulter Diagnostics, Merck (Sigma-Aldrich Co. LLC.), and Siemens Healthcare.

India Thyroid Function Test Market: Segmentation

• By Test Type
  • TSH
  • T3
  • T4
  • FT3
  • FT4
• By End User
  • Clinics
  • Research Organizations
  • Diagnostics Laboratories
  • Hospitals